Press release
October 1, 2019
Immunicom Secures an Additional $1.85 Million Bringing its Series B Funding to $12.85 Million
August 19, 2019
Immunicom Hosts Oncology Clinical Leaders at the 1st Annual Global Immunopheresis™ Clinical Conference in Krakow, Poland
July 2, 2019
Immunicom Secures $11 Million in Series B Investment Round
June 10, 2019
Immunicom Announces First Patient Enrollment in Multi-Center, Triple-Negative Breast Cancer Clinical Trial
May 14, 2018